VWM
GSK icon

Vermillion Wealth Management’s GSK GSK Stock Holding History

Vermillion Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Hold
277
– – ﹤0.01% 1012
2026
Q1 		$15.3K Hold
277
– – 0.01% 334
2025
Q4 		$13.6K Hold
277
– – 0.01% 331
2025
Q3 		$12K Buy
277
+131
+90% +$5.12K ﹤0.01% 1002
2025
Q2 		$5.61K Hold
146
– – ﹤0.01% 385
2025
Q1 		$5.66K Hold
146
– – ﹤0.01% 1090
2024
Q4 		$4.94K Buy
+146
New +$5.26K ﹤0.01% 394

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vermillion Wealth Management's GSK Position: Q2 2026 in Review

Vermillion Wealth Management held its GSK (GSK) position steady in Q2 2026 at 277 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Vermillion Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.3K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Vermillion Wealth Management held 277 shares of GSK worth $14.5K as of Q2 2026.
  • Vermillion Wealth Management left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1012 holding.
  • Vermillion Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's GSK position peaked at $15.3K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.